ERBB2 and breast carcinoma: Indeed, about 15–20% of breast cancers (BCs) harbor amplifications of the ERBB2 oncogene, which encodes for HER2, and this alteration leads to a more aggressive behavior of disease compared to HER2-negative (HER2–) cases [7, 8].